Home

About

HTA Compass

Blog

Podcast

Publications

Contact Us

Home

About

HTA Compass

Blog

Podcast

Publications

Contact Us

Blog

Rethinking JCA Readiness: Why BioPharma Needs Smarter Tools, Not Just More Consulting Projects

Sep 23, 2025

Two Worlds in Pharma Value Chain - Two Adoption Stories

Sep 25, 2025

Building Smarter Evidence: How One ATMP Company Future, Proofed Its Market Access Strategy

Sep 26, 2025

From Cost to Value: How to embed Value-Based Pricing into Launch Strategy

Sep 30, 2025

Building Credible, Relevant, and Timely Evidence in Oncology: How a Pharma Company Aligned Strategy Across an Alliance

Sep 30, 2025

Rethinking Evidence Generation for In-Licensed Assets: A Case from Follicular Lymphoma

Sep 30, 2025

Cracking the European Market: How a US Biotech Navigated HTA and Reimbursement for Its First Launch

Sep 30, 2025

Building Pricing Discipline in Gene Therapy: How SOPs Strengthened Global Market Access

Sep 30, 2025